Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

KB vs NMR: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

KB Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 7–2 Matrix Metrics)

KB Overall Winner 6-Pillar Tally: KB 4 – 1 NMR (1 Tie) Matrix Metrics: KB 7 – 2 NMR

As of Nov 17, 2026, KB Financial Group Inc (KB) is the stronger overall head-to-head candidate over Nomura Holdings, Inc (NMR) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KB carries a Unified Composite Score of 54.3/100 (HOLD) at $115.78 (0.0x Forward P/E, 26.2% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KB vs NMR
KB NYSE Head-to-Head Winner
KB Financial Group Inc
Commercial Banks, Nec
$115.78
-1.64% 1D
Market Cap $40.8B
TTM Revenue $23.4B
Forward P/E 0.0x
Beta / 30D Vol 1.33β · 29% Vol
Unified Composite Score
54.3 / 100 HOLD
Tech 49.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 48.2 · SMA20: $114.36 · SMA50: $120.71
NMR NYSE
Nomura Holdings, Inc
Security Brokers, Dealers & Flotation Companies
$9.34
-1.68% 1D
Market Cap $28.3B
TTM Revenue $14.9B
Forward P/E 12.7x
Beta / 30D Vol 1.03β · 29% Vol
Unified Composite Score
44.5 / 100 HOLD
Tech 47.0 Fund 49.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.5 · SMA20: $9.40 · SMA50: $9.68

6-Pillar Scorecard Institutional Category Breakdown (KB 4 – 1 NMR)

Columns: Metric · KB · NMR
1. Valuation Multiples KB
Forward P/E 0.0x 12.7x
Trailing P/E 10.1x 11.2x
PEG Ratio 0.71x 0.81x
EV / Revenue 1.7x 1.9x
2. Growth & Scale KB
Revenue Growth (YoY) +514.4% +17.9%
Earnings Growth (YoY) +21.1% +13.6%
TTM Revenue (USD) $23.4B $14.9B
Market Cap $40.8B $28.3B
3. Profitability & Quality KB
Gross Margin 100.0% 77.4%
Operating Margin 26.2% 25.1%
Net Profit Margin 17.2% 17.1%
Return on Equity (ROE) 10.2% 11.5%
4. Balance Sheet & Cash Flow NMR
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $30.20 Book/Sh · 10.2% ROE $8.17 Book/Sh · 11.5% ROE
Dividend Yield 2.82% 3.34%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 27.1% (7th %ile) 30.7% (<1st %ile)
Put/Call OI Skew Thin ADR Chain Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat KB
OpEx & R&D Intensity 73.8% of Rev ($17.3B) 52.3% of Rev ($7.77B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Banks - Regional Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KB (7) vs NMR (2)
Institutional Metric KB NMR Criterion Row Edge
Market Capitalization
Scale
$40.8B $28.3B Larger Scale KB
Trailing P/E Ratio
Valuation
10.1x 11.2x Lower Multiple KB
Forward P/E Ratio
Valuation
0.0x 12.7x Lower Multiple KB
Revenue Growth (YoY)
Growth
+514.4% +17.9% Higher Growth KB
Operating Margin (TTM)
Profitability
26.2% 25.1% Higher Margin KB
Net Profit Margin
Profitability
17.2% 17.1% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
10.2% 11.5% Higher ROE NMR
52-Week Range Position
Momentum
66% ($81–$133) 61% ($7–$11) Stronger Trend KB
Beta / 30D Volatility
Risk Regime
1.33β · 29% Vol 1.03β · 29% Vol Lower Realized Risk NMR
Unified Institutional Score
Composite Signal
54.3 / 100 (HOLD) 44.5 / 100 (HOLD) Higher Composite KB
Trailing 12M Revenue (USD)
Operating Scale
$23.4B $14.9B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
100.0% 77.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.71x PEG · 1.7x EV/Rev 0.81x PEG · 1.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($30.20 Book/Sh · 10.2% ROE) N/A ($8.17 Book/Sh · 11.5% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon NMR +5.23 pp
KB: -2.82% · NMR: +2.41%
3M Horizon KB +1.57 pp
KB: -0.22% · NMR: -1.79%
6M Horizon NMR +4.42 pp
KB: +12.33% · NMR: +16.75%
1Y Horizon KB +3.66 pp
KB: +30.05% · NMR: +26.39%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KB vs NMR. Trailing 12-month operating profitability (KB 26.2% vs NMR 25.1%) and valuation multiples (KB 0.0x vs NMR 12.7x Forward P/E) are benchmarked directly in Pillar 4 below.

KB ADR TTM Benchmark FX-Normalized USD
TTM Revenue$23.4B
Gross Margin100.0%
Op. Margin26.2%
ROE / Fwd P/E10.2% · 0.0x
NMR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14.9B
Gross Margin77.4%
Op. Margin25.1%
ROE / Fwd P/E11.5% · 12.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 27.1%
IV Percentile 7th %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NMR UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 30.7%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NMR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KB Moat Profile Scale & Operating Efficiency Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $40.8B market capitalization and 26.2% operating margin.
OpEx & R&D Reinvestment 73.8% of Rev ($17.3B)
90D Engineering Disclosures 0 Published
NMR Moat Profile Scale & Operating Efficiency Moat
Capital Markets Operator
Competes within the Capital Markets value chain with $28.3B market capitalization and 25.1% operating margin.
OpEx & R&D Reinvestment 52.3% of Rev ($7.77B)
90D Engineering Disclosures 0 Published

Investor FAQ KB vs NMR Key Questions & Quantitative Answers

As of Nov 17, 2026, KB Financial Group Inc (KB) is the stronger overall head-to-head candidate over Nomura Holdings, Inc (NMR) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KB carries a Unified Composite Score of 54.3/100 (HOLD) at $115.78 (0.0x Forward P/E, 26.2% operating margin), whereas NMR carries 44.5/100 (HOLD) at $9.34 (12.7x Forward P/E, 25.1% operating margin). Technically, KB sits in a Neutral phase (RSI 48.2, UNCLASSIFIED options structure) and NMR sits in a Neutral phase (RSI 45.5, UNCLASSIFIED options structure).

KB leads the Growth & Scale pillar: KB posts +514.4% YoY revenue growth and +21.1% YoY earnings growth on $23.4B TTM revenue (100.0% gross margin, 26.2% operating margin), compared with NMR at +17.9% YoY revenue growth and +13.6% YoY earnings growth on $14.9B TTM revenue (77.4% gross margin, 25.1% operating margin). On trailing 12-month operating scale, KB generates $23.4B in USD-normalized revenue versus $14.9B for NMR. In operating R&D and SG&A reinvestment, KB deploys 73.8% of Rev ($17.3B) (0 90-day corporate R&D disclosures) versus 52.3% of Rev ($7.77B) (0 disclosures) for NMR.

KB screens cheaper on headline valuation multiples. KB trades at 0.0x Forward P/E, 10.1x Trailing P/E, 0.71x PEG, and 1.7x EV/Revenue (unreported cash flow margin), whereas NMR trades at 12.7x Forward P/E, 11.2x Trailing P/E, 0.81x PEG, and 1.9x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KB (10.2% ROE) versus NMR (11.5% ROE) capital efficiency.

In options market volatility and institutional positioning, KB carries 27.1% implied volatility (7th %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.33β · 29% Vol realized risk). By comparison, NMR carries 30.7% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.03β · 29% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.